Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt Scientists Find Fingerprint for Lung Cancer

NEW YORK, Aug. 8 (GenomeWeb News) - A protein fingerprint of 15 proteins can be used to predict the prognosis of lung cancer patients, the Aug. 9 issue of the Lancet reported.


Scientists at VanderbiltUniversity showed that profiles obtained from small amounts of tissue fed through a mass spectrometer and analysis software could distinguish lung cancer tissue from normal tissue with 100 percent accuracy, and could also predict the risk of the cancer spreading to lymph nodes.


Since it was first introduced by Emanuel Petricoin, Lance Liotta, and others in the Feb. 2002 issue of Lancet, protein fingerprinting as a diagnostic tool has been studied for possible applications to ovarian, breast, prostate and lung cancer.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.